Delivery Order SPE2DB20D3101-SPE2DB23FRCQ7

Award Date 2/14/23
Potential Completion Date 2/15/23
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB20D3101|SPE2DB23FQYJ8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has a ceiling value of $11,758.17 and an ultimate completion date of December 28, 2022. It is a firm fixed-price contract, with no set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,030.70 firm fixed-price delivery order is for Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has an ultimate completion date of January 5, 2024. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,663.88, is for the delivery of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Sandostatin LAR Depot 30 mg kits. The award, valued at $12,669.03, is a Firm Fixed Price delivery order contract with an ultimate completion date of August 7, 2024. The contract does not have a set-aside designation. As a prime contractor, AmerisourceBergen will be responsible for supplying this critical pharmaceutical product...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,496.64, is for the delivery of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has an ultimate completion date of April 7, 2023 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,439.73 firm fixed-price delivery order is for the supply of Sandostatin LAR Depot 10 mg kits, a specialty medication. The contract has an ultimate completion date of July 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $9,423.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of June 24, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,714.57, is for the delivery of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. The award has an ultimate completion date of February 7, 2025. In addition to this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,336.65 firm fixed-price delivery order contract is for the provision of Sandostatin LAR Depot 20 mg kits, a specialty medication. The contract has an ultimate completion date of November 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,240.63 firm-fixed-price delivery order is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The award is part of a $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRCQ7
    Delivery Order

This federal contract award, with the ID SPE2DB20D3101|SPE2DB23FRCQ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,204.98, is for the delivery of Sandostatin LAR Depot 30 mg kits. It is a firm fixed-price delivery order contract with a completion date of February 15, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:14 AM